VIDEO: New medications help ease DME treatment burden

Editor's note: This is an automatically generated transcript. Please notify editor@healio.com if there are concerns regarding accuracy of the transcription.

I think one of the things that is really frustrating to retina specialists is the fact that maybe we have a clinic that’s sort of booming with patients, and we’ve got to do injection after injection after injection, and patients are coming back and they’re just saying, “I was just here, doc.” And you know, so I think, as it comes down to treatment burden, that’s kind of one of the real joys of where we are in 2023. I think both faricimab as well as 8 mg aflibercept have been able to extend the duration for some of my patients who were previously on other medications. I’d love to see that interval get continuously extended further. I think steroids help a lot in that window where you have the dexamethasone implant as well as the fluocinolone implant. Those allow for much longer duration medications, but even then, I’m still bringing those patients in for intraocular pressure check.